Core Laboratories N.V. (CLB) is a Oil & Gas Equipment & Services company in the Energy sector, currently trading at $16.27. It has a SharesGrow Score of 62/100, indicating a above average investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of CLB = $57.34 (+252.4% from the current price, the stock appears undervalued). Analyst consensus target is CLB = $25 (+53.7% upside).
Valuation: CLB trades at a trailing Price-to-Earnings (P/E) of 24.7 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 2.05.
Financials: revenue is $527M, +2.5%/yr average growth. Net income is $32M, growing at +25.1%/yr. Net profit margin is 6% (thin). Gross margin is 17.9% (+1.8 pp trend).
Balance sheet: total debt is $206M against $280M equity (Debt-to-Equity (D/E) ratio 0.74, moderate). Current ratio is 2.07 (strong liquidity). Debt-to-assets is 34.6%. Total assets: $597M.
Analyst outlook: 16 / 37 analysts rate CLB as buy (43%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 65/100 (Pass), Growth 73/100 (Pass), Past 100/100 (Pass), Health 67/100 (Partial), Moat 32/100 (Fail), Future 52/100 (Partial), Income 45/100 (Partial).
